Oxidative stress in relation to adenosine deaminase, nitric oxide, nitric oxide synthase and xanthine oxidase in oral cavity cancer

Yıl 2018, Cilt: 4 Sayı: 1, 38 - 43, 04.01.2018

Ayca Ant Erdogan Inal Aslihan Avci Metin Genc Umit Tuncel Ziya Sencan Yasemin Genc

https://doi.org/10.18621/eurj.322520

Öz

Inflammation and oxidative stress
are considered as the main pathways in oral cavity carcinoma. The aim of this study was to evaluate the
activity levels of adenosine deaminase (ADA), nitric oxide (NO),
nitric oxide synthase (NOS), and xanthine oxidase (XO) in oral
cavity carcinoma, to determine their potential roles in carcinogenesis with
relation to oxidative stress. Methods. Seventeen patients with
oral cavity cancer underwent surgery as the primary therapy, were consisted in
the study. Resected oral cavity carcinoma tissues were compared with the
adjacent tumor-free control tissues of the same patients; ADA, NO, NOS, XO
activity levels were evaluated in terms of difference. Results. There is a
significant increase of ADA activity in squamous cell cancer tissues, which
indicates a difference between the normal and tumor tissues at enzyme levels (p<0.001). Conclusion. Elevated ADA activity might be an attempt to
supress formation of the immunosupressed niche which promotes the onset of
neoplasia and/or to inhibit tumor progression and metastasis. 

Anahtar Kelimeler

Adenosine deaminase, nitric oxide, nitric oxide synthase, oral cancer, oxidative stress, xanthine oxidase

Kaynakça

• [1] Cummings CW, Flint PW, Harker LA, Haughey BH, Richardson MA, Robbins KT, et al. Otolaryngology-Head and Neck Surgery, 4th ed. Mosby, Inc: Philadelphia, 2005;2:1578-617. iladelphia 2005; 2: 1578-1617.
• [2] Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
• [3] Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
• [4] Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promotor in cancer induction. Semin Cancer Biol 2004;14:433-9.
• [5] Gavilanes J, Moro MA, Lizasoain I, Lorenzo P, Perez A, Leza JC, et al. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck. Laryngoscope 1999;109:148-52.
• [6] Garca MF, Demir H, Turan M, Bozan N, Kozan A, Belli SB, et al. Assessment of adenosine deaminase (ADA) activity and oxidative stress in patients with chronic tonsillitis. Eur Arch Otorhinolaryngol 2014;271:1797-802.
• [7] Lokshin A, Tatiana R, Huang X, Zacharia LC, Jackson ED, Gorelik E. Adenosine-mediated inhibition of the cytotoxic activity and production by activated natural killer cells. Cancer Res 2006;66:7758-65.
• [8] Guisti G. Methods of enzymatic analysis. Vol 2. Bergmeyer HV Ed. New York: Academic Press, 1974:1092-9.
• [9] Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84: 9265-9.
• [10] Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium- dependent vasodilatation in experimental diabetes. J Clin Invest 1991;87:432-8.
• [11] Hashimato S. A new spectrophotometric assay method of xanthine oxidase in crude tissue homogenate. Anal Biochem 1974;62:425-35.
• [12] Antonioli L, Blandizzi C, Pacher P, Hasko G. Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 2013;13:842-57.
• [13] Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A. Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 2008;14:5947-52.
• [14] Ryzhov S, Novitskiy SV, Zaynagetdinov R, Goldstein AE, Carbone DP, Biaggioni I, et al. Host A(2B) adenosine receptors promote carcinoma growth. Neoplasia 2008:10;987-95.
• [15] Ashok KJ, Pinto GJO, Kavitha AK, Palathra MJ. The diagnostic and prognostic value of serum adenosine deaminase levels in head and neck cancer. J Clin Diagn Res 2008;10:833-7.
• [16] Rai B, Kaur J, Jacobs R, Anand SC. Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue. Clin Oral Investig 2011:15;347-9.
• [17] Kelgandre DC, Pathak, J, Patel, S, Ingale P, Swain N. Adenosine deaminase - a novel diagnostic and prognostic biomarker for oral squamous cell carcinoma. Asian Pac J Cancer Prev 2016;17:1865-8.
• [18] Dasmahapatra KS, Hill HZ, Dasmahapatra A, Suarez S. Evaluation of adenosine deaminase activity in patients with head and neck cancer. J Surg Res 1986;40:368-73.
• [19] Saracoglu U, Guven O, Durak I. Adenosine deaminase and 5’-nucleotidase activities in saliva from patients with oral and laryngeal cancer. Oral Dis 2005;11:323-5.
• [20] Linden J. Adenosine metabolism and cancer. Focus on “Adenosine downregulates DPPIV on HT‑29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway”. Am J Physiol Cell Physiol 2006: 291;C405-6.
• [21] McMullin BB, Chittock DR, Roscoe DL, Garcha H, Wang L, Miller CC. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit. Respir Care 2005;50:1451-6.
• [22] Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res 2002;12:311-20.
• [23] Li LM, Kilbourn RG, Adams J, Fidler IJ. The role nitric oxide in lysis of tumor cells by cytoxine activated endothelial cells. Cancer Res 1991; 51:2531-5.
• [24] Avci A, Tuzuner-Oncul AM, Gokcan MK, Namuslu M, Ozturk A, Durak I. Nitric oxide metabolism in cancerous and non-cancerous oral gingivomucosal tissue: possible implications of nitric oxide in cancer process. J Oral Pathol Med 2009;38:304-6.